Spruce Biosciences Stock (NASDAQ: SPRB) stock price, news, charts, stock research, profile.
Open | $0.43 |
Close | - |
Volume / Avg. | 272.83K / 439.83K |
Day Range | $0.43 - $0.45 |
52 Wk Range | 0.41 - 5.95 |
Market Cap | $18.43M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 0.64% |
Days to Cover | 1.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spruce Biosciences (NASDAQ:SPRB) through any online brokerage.
Other companies in Spruce Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
Spruce Biosciences has a consensus price target of $4.29.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $0.4463 last updated September 23, 2024 at 10:19 AM EDT.
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.